3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
14
Lung Neoplasms
8
Prostatic Neoplasms
6
Colorectal Neoplasms
6
Neoplasms
5
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Lymphoma
3
Smoking Cessation
2
Skin Carcinoma
2
Pain
2
Melanoma
2
Malignant Solid Neoplasm
2
Leukemia, Myeloid, Acute
2
Hematopoietic and Lymphatic System Neoplasm
2
Carcinoma, Non-Small-Cell Lung
2
Anatomic Stage I Breast Cancer AJCC v8
2
Advanced Malignant Solid Neoplasm
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Tobacco Smoking
1
Testicular Neoplasms
1
Spondylitis, Ankylosing
1
Smoking
1
Signs and Symptoms
1
Sepsis
1
Rectal Neoplasms
1
Psoriasis
1
Interventions
Echocardiography
2
empagliflozin
1
Social Determinants of Health
1
Hematologic Tests
1
Environmental Biomarkers
1
Carvedilol
1
Cardiography, Impedance
1
Blood Pressure Determination
1
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Methods
×
90 days
×
Clear all
No trials found.